This federal contract award from the Defense Logistics Agency (DLA) to Fresenius Kabi, LLC is a $53,143.79 delivery order for the supply of Doxycycline Hydrochloride Injection (10) to support military medical facilities. The contract has a period of performance through September 27, 2024 and was awarded on a firm fixed price basis without a set-aside designation. Fresenius Kabi, a foreign-owned, for-profit pharmaceutical company headquartered in Lake Zurich, Illinois, provides a wide range of injectable medications and medical solutions to the U.S. federal government, including the Department of Veterans Affairs and the Department of Defense. This contract demonstrates Fresenius Kabi's ability to consistently manufacture and supply critical care pharmaceuticals to support military healthcare operations.
Generated 12/24/24, 9:25 AM